New Oxford/AstraZeneca’s Coronavirus Vaccine To Cost Just £2 Per Dose
Britain could have 19million doses of Oxford and AstraZeneca‘s coronavirus vaccine by the end of the year after clinical trials showed it is up to 90 per cent effective at preventing infection and can be stored cheaply in a fridge. President of AstraZeneca, Tom Keith-Roach said today that, on top of the four million doses on standby for the UK, a further 15million could be ready to roll out by the end of next month. They will be given to healthcare workers and the elderly first, subject to approval by regulators.
The vaccine is expected to cost just £2 per dose and can be stored in ordinary equipment, unlike other jabs made by Pfizer and Moderna that showed similarly promising results last week but need to be kept in ultra-cold temperatures using expensive equipment. It’s also a fraction of the price, with Pfizer‘s costing around £15 per dose and Moderna‘s priced at about £26 a shot.
Oxford‘s trials found the jab has a nine in ten chance of working when administered as a half dose first and then a full dose a month later. Efficacy drops to 62 per cent when someone is given two full doses a month apart.